FindOwnerSearch
Brands and Their Owners
Welcome to the Brand page for “PRONUCLEON”, which is offered here for Biomedical compounds, peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use; synthetic peptides for pharmaceutical purposes; testing kits containing peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use; medical diagnostic reagents and assays for testing of bodily fluids; contrasting agent for ultrasound diagnostic imaging;biomedical compounds, peptide substrates used in analyzing and detecting certain toxins for laboratory or research use; assays and reagents for use in genetic research; testing kits containing peptide substrates used in analyzing and detecting certain toxins for laboratory or research use;pharmaceutical research and development services, assay development, compound screening, compound ad chemical identification, drug target identification and characterization, performance of human clinical trials;.
Its status is currently believed to be active. Its class is unavailable. “PRONUCLEON” is believed to be currently owned by “Adlyfe, Inc.”
| Owner: | 
                ADLYFE, INC.
            Owner Details | 
|---|---|
| Description: | 
            Biomedical compounds, peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use; synthetic peptides for pharmaceutical purposes; testing kits containing peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use; medical diagnostic reagents and assays for testing of bodily fluids; contrasting agent for ultrasound diagnostic imaging;Biomedical compounds, peptide substrates used in analyzing and detecting certain toxins for laboratory or research use; assays and reagents for use in genetic research; testing kits containing peptide substrates used in analyzing and detecting certain toxins for laboratory or research use;Pharmaceutical research and development services, assay development, compound screening, compound ad chemical identification, drug target identification and characterization, performance of human clinical trials;
         | 
| Categories: | BIOMEDICAL COMPOUNDS |